CIVCO Medical Solutions, a leading manufacturer of ultrasound guidance devices and infection control products, announces that it has acquired PCI Medical, a market leader in high-level disinfection products for ultrasound transducers. The acquisition equips CIVCO with a portfolio of hardware and consumables to meet the growing need for cost effective infection control compliance in the ultrasound transducer reprocessing market.
PCI Medical, established 20 years ago in Deep River, Conn., has held a leading position in the infection control market for transducer high-level disinfection and storage devices designed to help meet Joint Commission and FDA guidelines.
The PCI product line complements the CIVCO offering of ultrasound infection control transducer covers, needle guidance systems and interventional procedure kits. CIVCO's Multi-Modality Imaging (MMI) business unit has been a distributor of PCI storage racks and soaking systems in the U.S. for more than 10 years.
The addition of the new ASTRA family of devices, which received 510(K) clearance in November of 2015, extends CIVCO's reach into cardiology and men's and women's health segments. The ASTRA TEE, designed for automatic high-level disinfection of transesophageal ultrasound probes, and the ASTRA VR, designed for automated high-level disinfection of transvaginal and transrectal probes, enable clinicians to develop a standardized workflow, save time, and automate the record keeping process. These devices help facilities follow guidelines established by the Joint Commission and FDA for transducer reprocessing and storage.
"We are excited to expand our portfolio to include the ASTRA and GUS product lines for infection control management," said Charles Klasson, president of CIVCO. "This offering fits well with our current call points in radiology, men's and women's health and infection control departments, and will help CIVCO to expand our presence in the U.S."
Source: CIVCO Medical Solutions
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.